Cargando…

Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease

BACKGROUND: Iron deficiency is highly prevalent in chronic kidney disease (CKD) patients. In clinical practice, iron deficiency is defined based on a combination of two commonly used markers, ferritin and transferrin saturation (TSAT). However, no consensus has been reached which cutoffs of these pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eisenga, Michele F., Nolte, Ilja M., van der Meer, Peter, Bakker, Stephan J. L., Gaillard, Carlo A. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134584/ https://www.ncbi.nlm.nih.gov/pubmed/30208847 http://dx.doi.org/10.1186/s12882-018-1021-3

Ejemplares similares

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

Iron deficiency, with and without anaemia, across strata of kidney function in kidney transplant recipients
por: Ayerdem, Gizem, et al.
Publicado: (2021)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
por: Hofman, Jesse M. G., et al.
Publicado: (2018)

Iron Deficiency and Nephrotoxic Heavy Metals: A Dangerous Interplay?
por: Rawee, Pien, et al.
Publicado: (2023)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Epoetin Beta and C‐Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease
por: Eisenga, Michele F., et al.
Publicado: (2019)

Iron deficiency after kidney transplantation
por: Vinke, Joanna Sophia J, et al.
Publicado: (2020)

Iron Deficiency Defined by Hepcidin in Critically Ill Patients
por: Eisenga, Michele F.
Publicado: (2021)

Iron deficiency is related to lower muscle mass in community‐dwelling individuals and impairs myoblast proliferation
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023)

Iron deficiency and cognitive functioning in kidney transplant recipients: findings of the TransplantLines biobank and cohort study
por: Vinke, Joanna Sophia J, et al.
Publicado: (2023)

Association of hepcidin‐25 with survival after kidney transplantation
por: Eisenga, Michele F., et al.
Publicado: (2016)

Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study
por: Douwes, Rianne M., et al.
Publicado: (2021)

Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx): rationale and study protocol for a double-blind, randomised, placebo-controlled trial
por: Vinke, Joanna SJ, et al.
Publicado: (2023)

Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
por: Post, Adrian, et al.
Publicado: (2020)

Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
por: Chia, Yook Chin, et al.
Publicado: (2021)

Urinary prednisolone excretion is a determinant of serum hepcidin levels in renal transplant recipients
por: Eisenga, Michele F., et al.
Publicado: (2017)

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
por: Macdougall, Iain C., et al.
Publicado: (2014)

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Treatment of iron deficiency in patients scheduled for pancreatic surgery: implications for daily prehabilitation practice in pancreatic surgery
por: Wijma, Allard G., et al.
Publicado: (2023)

Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023)

Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival
por: Wisse, Bram W., et al.
Publicado: (2019)

Changes in Iron Status Biomarkers with Advancing Age According to Sex and Menopause: A Population-Based Study
por: Merlo, Francesco, et al.
Publicado: (2023)

Active smoking and macrocytosis in the general population: Two population‐based cohort studies
por: Eisenga, Michele F., et al.
Publicado: (2018)

Plasma Thallium Concentration, Kidney Function, Nephrotoxicity and Graft Failure in Kidney Transplant Recipients
por: Kremer, Daan, et al.
Publicado: (2022)

Low Urinary Creatinine Excretion Is Associated With Self-Reported Frailty in Patients With Advanced Chronic Kidney Disease
por: Polinder-Bos, Harmke A., et al.
Publicado: (2017)

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
por: Alnuwaysir, Ridha I. S., et al.
Publicado: (2021)

Hand dexterity, daily functioning and health-related quality of life in kidney transplant recipients
por: Knobbe, Tim J., et al.
Publicado: (2022)

Association of Endogenous Erythropoietin Levels and Iron Status With Cognitive Functioning in the General Population
por: Ayerdem, Gizem, et al.
Publicado: (2022)

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: De Jong, Maarten A, et al.
Publicado: (2020)

Prenatal Iron Deficiency and Replete Iron Status Are Associated with Adverse Birth Outcomes, but Associations Differ in Ghana and Malawi
por: Oaks, Brietta M, et al.
Publicado: (2019)

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
por: van Veldhuisen, Dirk J., et al.
Publicado: (2017)

Locally validated biomarker cutoffs should inform micronutrient deficiency burdens
por: Sachdev, Harshpal Singh, et al.
Publicado: (2023)

Altered Gut Microbial Fermentation and Colonization with Methanobrevibacter smithii in Renal Transplant Recipients
por: Knobbe, Tim J., et al.
Publicado: (2020)

Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
por: Khatami, Farnaz, et al.
Publicado: (2022)

Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro
por: van Bladel, Esther R, et al.
Publicado: (2012)

Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study
por: Byambasukh, Oyuntugs, et al.
Publicado: (2019)

Boron Intake and decreased risk of mortality in kidney transplant recipients
por: Kremer, Daan, et al.
Publicado: (2021)

Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome
por: Kremer, Daan, et al.
Publicado: (2021)

The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
por: van Vuren, Annelies J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gsgfi6d0ka21ebrjd20qdieait